Search

everythinglearnresearchcommunity

for

Search:↓

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

Platelet-rich plasma shows promise for treating various female reproductive health issues but requires more research.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Malva verticillata seed extracts, specifically linoleic acid, can help reduce hair loss and promote hair growth by activating certain cell signals.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

Skin symptoms can indicate endocrine disorders and have various treatments.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Watercress extract helps increase hair growth and thickness by blocking hair loss factors.

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.

Birth control pills can improve or cause acne and hair issues, with improvements more common, and may affect skin pigmentation.

Certain genetic variants impair enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

A woman's ovarian tumor causing high testosterone was successfully removed, and her symptoms improved.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

Androgen levels can increase at any age, affecting symptoms like acne, hair loss, and prostate size.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

AAG causes hair loss in many people, with limited treatments like finasteride, minoxidil, light therapy, and hair transplants.

As women age, they experience changes in hair density and volume, face challenges in distinguishing normal hair loss from disease, and have limited access to treatments for hair issues.

The meeting covered advances in understanding hair growth, causes of hair loss, and potential treatments.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.